Investigating the role of class-IA PI 3-kinase isoforms in adipocyte differentiation

Biochemical and Biophysical Research Communications

Volumn 379, Issue 4, 2009, Pages 830-834

  Kim, Ji Eun ^a   Shepherd, Peter R ^a   Chaussade, Claire ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Adipocyte differentiation; Off target activity; PI 3 kinase; PI3K isoform specific inhibitors; PIK3CA; Signal transduction

Indexed keywords

2 (6 AMINO 9 PURINYLMETHYL) 5 METHYL 3 (2 METHYLPHENYL) 3H QUINAZOLIN 4 ONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 9 (1 ANILINOETHYL) 7 METHYL 2 MORPHOLINOPYRIDO[1,2 A]PYRIMIDIN 4 ONE; ADIPOPHILIN; DIMETHYL SULFOXIDE; MEMBRANE RECEPTOR; MORPHOLINE; OXAZINE DERIVATIVE; PHOSPHOTRANSFERASE; PI 3 KINASE; PROTEIN P110; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; ATTENUATION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; FIBROBLAST; HUMAN; HUMAN CELL; LIPID STORAGE; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; ISOENZYMES; MICE;

EID: 58949104572     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.12.089     Document Type: Article

References (29)

1. Flier J.S. The adipocyte: storage depot or node on the energy information superhighway. Cell 80 (1995) 15-18
2. Green H., and Kehinde O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5 (1975) 19-27
3. Fajas L., Schoojans K., Gelman L., Kim J.B., Najib J., Martin G., Fruchart J., Briggs M., Spiegelman B.M., and Auwerx J. Regulation of PPARg expression in adipocyte differentiation. Mol. Cell. Biol. 19 (1999) 5495-5503
4. Christy R.J., Wang V.W., Ntambi J.M., Geiman D.E., Landschulz W.H., Friedman A.D., Nakabeppu Y., Kelly T.J., and Lane M.D. Differentiation induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts and activates the promoters of two adipocyte specific genes. Genes Dev. 3 (1989) 1323-1335
5. Ntambi J.M., and Young-Cheul K. Adipocyte differentiation and gene expression. J. Nutr. 130 (2000) 3122S-3126S
6. Spiegelman B.M., Choy L., Hotamisigil G.S., Graves R.A., and Tontonoz P. Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J. Biol. Chem. 268 (1993) 6823-6826
7. Bennett C.N., Ross S.E., Longo K.A., Bajnok L., Hemati N., Johnson K.W., Harrison S.D., and MacDougald O.A. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277 (2002) 30998-31004
8. Christodoulides C., Laudes M., Cawthorn W.P., Schinner S., Soos M., O'rahilly S., Sethi J.K., and Vidal-Puig A. The Wnt antagonist Dickkopf-1 and its receptors are co-ordinately regulated during early human adipogenesis. J. Cell Sci. 119 (2006) 2613-2620
9. Kennell J.A., and MacDougald O.A. Wnt signaling inhibits adipogenesis through {beta}-catenin dependent and independent mechanisms. J. Biol. Chem. 280 (2005) 24004-24010
10. Sakaue H., Ogawa W., Matsumoto M., Kuroda S., Takata M., Sugimoto T., Spiegelman B.M., and Kasuga M. Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase. J. Biol. Chem. 273 (1998) 28945-28952
11. Tomiyama K., Nishio E., and Watanabe Y. Both wortmannin and simvastatin inhibit the adipogenesis in 3T3-L1 cells during the late phase of differentiation. Jpn. J. Pharmacol. 80 (1999) 375-378
12. Tomiyama K., Sasa H., Arimura S., Nishio E., and Watanabe Y. Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 212 (1995) 263-269
13. Xia X., and Serrero G. Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors. J. Cell. Physiol. 178 (1999) 9-16
14. Usui I., Haruta T., Iwata M., Takano A., Uno T., Kawahara J., Ueno E., Sasaoka T., and Kobayashi M. Retinoblastoma protein phosphorylation via PI 3-kinase and mTOR pathway regulates adipocyte differentiation. Biochem. Biophys. Res. Commun. 275 (2000) 115-120
15. Aubin D., Gagnon A., and Sorisky A. Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture. Int. J. Obes. (Lond.) 29 (2005) 1006-1009
16. Shepherd P.R. Mechanisms regulating phosphoinositide 3-kinase signalling in insulin sensitive tissues. Acta Physiol. Scand. 183 (2005) 3-12
17. Asano T., Kanda A., Katagiri H., Nawano M., Ogihara T., Inukai K., Anai M., Fukushima Y., Yazaki Y., Kikuchi M., Hooshmand-Rad R., Heldin C., Oka Y., and Funaki M. p110 beta is up-regulated during differentiation of 3T3-L1 cells and contributes to the highly insulin-responsive glucose transport activity. J. Biol. Chem. 275 (2000) 17671-17676
18. Zhao J.J., Cheng H., Jia S., Wang L., Gjoerup O.V., Mikami A., and Roberts T.M. The p110alpha isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation. Proc. Natl. Acad. Sci. USA 103 (2006) 16296-16300
19. Yun S.J., Kim E.K., Tucker D.F., Kim C.D., Birnbaum M.J., and Bae S.S. Isoform-specific regulation of adipocyte differentiation by Akt/protein kinase Balpha. Biochem. Biophys. Res. Commun. 371 (2008) 138-143
20. Magun R., Burgering B.M.T., Coffer P.J., Pardasani D., Lin Y., Chabot J., and Sorisky A. Expression of a constitutively active form of protein kinase B in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology 137 (1996) 3590-3593
21. Workman P. Inhibiting the phosphoinositide 3-kinase pathway for cancer treatment. Biochem. Soc. Trans. 32 (2004) 393-396
22. Marone R., Cmiljanovic V., Giese B., and Wymann M.P. Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim. Biophys. Acta 1784 (2008) 159-185
23. Chaussade C., Rewcastle G.W., Kendall J.D., Denny W.A., Cho K., Gronning L.M., Chong M.L., Anagnostou S.H., Jackson S.P., Daniele N., and Shepherd P.R. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochem. J. 404 (2007) 449-458
24. Beeton C.A., Chance E.M., Foukas L.C., and Shepherd P.R. Comparison of the kinetic properties of the lipid and protein kinase activities of the p110α and p110β catalytic subunits of class Ia PI 3-kinases. Biochem. J. 350 (2000) 353-359
25. Knight Z.A., Gonzalez B., Feldman M.E., Zunder E.R., Goldenberg D.D., Williams O., Loewith R., Stokoe D., Balla A., Toth B., Balla T., Weiss W.A., Williams R.L., and Shokat K.M. A pharmacological map of the PI3-K family defines a role for p110α in insulin signalling. Cell 125 (2006) 1-15
26. Jackson S.P., Schoenwaelder S.M., Goncalves I., Nesbitt W.S., Yap C.L., Wright C.E., Kenche V., Anderson K.E., Dopheide S.M., Yuan Y., Sturgeon S.A., Prabaharan H., Thompson P.E., Smith G.D., Shepherd P.R., Daniele N., Kulkarni S., Abbott B., Saylik D., Jones C., Lu L., Giuliano S., Hughan S.C., Angus J.A., Robertson A.D., and Salem H.H. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nature Med. 11 (2005) 507-514
27. Sadhu C., Dick K., Tino W.T., and Staunton D.E. Selective role of PI3K delta in neutrophil inflammatory responses. Biochem. Biophys. Res. Commun. 308 (2003) 764-769
28. Foukas L.C., Claret M., Pearce W., Okkenhaug K., Meek S., Peskitt E., Sancho S., Smith A.J.H., Withers D.J., and VanHaesebroeck B. Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441 (2006) 366-370
29. Okkenhaug K., Bilancio A., Farjot G., Priddle H., Sancho S., Peskett E., Pearce W., Meek S.E., Salpekar A., Waterfield M.D., Smith A.J.H., and Vanhaesebroeck B. Impaired B and T cell antigen receptor signaling in p110 PI 3-kinase mutant mice. Science 297 (2002) 1031-1034